Cancer Research UK and CRIS fund lung cancer vaccine research

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

Mar 26, 2024 - 00:00

Cancer Research UK and CRIS fund lung cancer vaccine research

Cancer Research UK and the CRIS Cancer Foundation have awarded a £1.7m ($2.1m) grant for developing the lung cancer vaccine LungVax.

Read the original article

Tags:

Previous Article

FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension

FDA approves Takeda’s Iclusig for Philadelphia chromosome-positive ALL

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Izokibep by Acelyrin for Panuveitis: Likelihood of Appr...

Jun 5, 2023

FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria

FDA reviews Sanofi and Regeneron’s Dupixent label expan...

Nov 17, 2024

Opinion: There’s a less intimidating alternative to EpiPens for dangerous allergic reactions. Why won’t the FDA approve it?

Opinion: There’s a less intimidating alternative to Epi...

Dec 29, 2023